Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | PYGB | P11216 | 4/20 | 0.46 |
| ▸ | GBA1 | P04062 | 6/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CD69 | Q07108 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10529893 | 1.00 | MAPK1 (0.61) | MAPK1ALDH1A1THRBPYGBGBA1 | |
| SCHEMBL23136470 | 1.00 | MAPK1 (0.61) | MAPK1ALDH1A1THRBPYGBGBA1 | |
| SCHEMBL10625975 | 1.00 | MAPK1 (0.61) | MAPK1ALDH1A1THRBPYGBGBA1 | |
| SCHEMBL24645911 | 0.95 | MAPK1 (0.57) | MAPK1ALDH1A1THRBPYGBGAA | |
| SCHEMBL10598091 | 0.88 | PYGB (0.53) | MAPK1PYGBGBA1GAA | |
| SCHEMBL10812315 | 0.88 | PYGB (0.53) | MAPK1PYGBGBA1GAA | |
| SCHEMBL16217898 | 0.84 | ALDH1A1 (0.54) | MAPK1ALDH1A1THRBPYGBGAA | |
| SCHEMBL22692620 | 0.81 | MAPK1 (0.58) | MAPK1ALDH1A1THRBPYGBGAA | |
| SCHEMBL5498712 | 0.81 | MAPK1 (0.57) | MAPK1ALDH1A1THRBPYGBGAA | |
| SCHEMBL5498717 | 0.81 | MAPK1 (0.57) | MAPK1ALDH1A1THRBPYGBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4710491-A | N-glycosylated carboxylic acid derivatives as agents for combating rheumatic diseases | TROPONWERKE GMBH & CO., KG (DE) | 1987-12-01 | — | — | US | disclosed |
| US-4683222-A | STIMULANTS FOR IMMUNE SYSTEM | BAYER AKTIENGESELLSCHAFT (DE) | 1987-07-28 | — | — | US | disclosed |
| US-4680287-A | N-glycosylated carboxamide derivatives as growth-promoters in livestock feeding | BAYER AKTIENGESELLSCHAFT (DE) | 1987-07-14 | — | — | US | disclosed |
| EP-0091645-B1 | DERIVATIVES OF AMIDES OF CARBOXYLIC ACIDS IN WHICH THE N ATOM IS SUBSTITUTED BY A GLYCOSYL RADICAL, METHOD FOR THEIR PREPARATION AND THEIR USE TO INFLUENCE THE IMMUNOGENIC SYSTEM | BAYER AG (DE) | 1987-02-25 | — | — | EP | disclosed |
| EP-0147777-A2 | Derivatives of M-glycosylated amides of carboxylic acids as a product for combating diseases of the rheumatism type | Troponwerke GmbH & Co. KG (DE) | 1985-07-10 | — | — | EP | disclosed |
| EP-0140321-A2 | Use of derivatives of amides of carboxylic acids in which the N atom is substituted by a glycosyl radical as growth promotor in animal nutrition | BAYER AG (DE) | 1985-05-08 | — | — | EP | disclosed |
| EP-0091645-A1 | Derivatives of amides of carboxylic acids in which the N atom is substituted by a glycosyl radical, method for their preparation and their use to influence the immunogenic system | BAYER AG (DE) | 1983-10-19 | — | — | EP | disclosed |